Tinavi Medical Technologies Co Ltd (688277) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, Tinavi Medical Technologies Co Ltd (688277) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥24.50 Million ≈ $3.59 Million USD) by net assets (CN¥1.29 Billion ≈ $189.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Tinavi Medical Technologies Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Tinavi Medical Technologies Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Tinavi Medical Technologies Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tinavi Medical Technologies Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tinavi Medical Technologies Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Mahanagar Gas Limited
NSE:MGL
0.083x
Anadolu Anonim Turk Sigorta Sti
IS:ANSGR
0.069x
Amalgamated Bank
NASDAQ:AMAL
0.070x
Bristow Group Inc
NYSE:VTOL
-0.008x
Iat Automobile Technology Co Ltd
SHE:300825
0.019x
Manchester United Ltd
NYSE:MANU
0.005x
Radiant Opto-Electronics Corp
TW:6176
-0.005x
Hyprop
JSE:HYP
0.034x

Annual Cash Flow Conversion Efficiency for Tinavi Medical Technologies Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Tinavi Medical Technologies Co Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see Tinavi Medical Technologies Co Ltd market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥3.01 Billion
≈ $439.93 Million
CN¥-51.17 Million
≈ $-7.49 Million
-0.017x +77.92%
2024-12-31 CN¥1.28 Billion
≈ $187.32 Million
CN¥-98.65 Million
≈ $-14.44 Million
-0.077x +44.06%
2023-12-31 CN¥1.24 Billion
≈ $181.09 Million
CN¥-170.50 Million
≈ $-24.95 Million
-0.138x -75.95%
2022-12-31 CN¥1.12 Billion
≈ $163.54 Million
CN¥-87.51 Million
≈ $-12.80 Million
-0.078x -7.51%
2021-12-31 CN¥1.07 Billion
≈ $156.22 Million
CN¥-77.76 Million
≈ $-11.38 Million
-0.073x -29.85%
2020-12-31 CN¥1.03 Billion
≈ $150.22 Million
CN¥-57.58 Million
≈ $-8.43 Million
-0.056x -262.91%
2019-12-31 CN¥596.34 Million
≈ $87.26 Million
CN¥20.53 Million
≈ $3.00 Million
0.034x +46.76%
2018-12-31 CN¥560.61 Million
≈ $82.04 Million
CN¥13.15 Million
≈ $1.92 Million
0.023x -30.62%
2017-12-31 CN¥169.41 Million
≈ $24.79 Million
CN¥5.73 Million
≈ $838.18K
0.034x +114.13%
2016-12-31 CN¥136.62 Million
≈ $19.99 Million
CN¥-32.70 Million
≈ $-4.78 Million
-0.239x -216.74%
2015-12-31 CN¥203.98 Million
≈ $29.85 Million
CN¥41.82 Million
≈ $6.12 Million
0.205x +132.02%
2014-12-31 CN¥52.84 Million
≈ $7.73 Million
CN¥-33.84 Million
≈ $-4.95 Million
-0.640x -460.95%
2013-12-31 CN¥29.60 Million
≈ $4.33 Million
CN¥-3.38 Million
≈ $-494.53K
-0.114x --

About Tinavi Medical Technologies Co Ltd

SHG:688277 China Medical Instruments & Supplies
Market Cap
$1.27 Billion
CN¥8.65 Billion CNY
Market Cap Rank
#8065 Global
#1944 in China
Share Price
CN¥18.98
Change (1 day)
+4.80%
52-Week Range
CN¥12.79 - CN¥27.95
All Time High
CN¥141.60
About

Tinavi Medical Technologies Co.,Ltd. engages in the research and development, production, sale, market, service, and clinical application of orthopedic surgery robots and related technologies. The company offers TiRobot II, an orthopedic robotic system to create an operation center; TiRobot, an orthopedic robotic system used in implants in surgery for spine and trauma; 5G remote surgery systems; … Read more